Results in 12 hours or less.


Fast COVID-19 testing in North Oakland

About the test


Results in 12 hours or less, no symptoms or referral needed

Accepted for travel

Meets nearly all air travel requirements


Highly accurate qRT-PCR test


Drive-through testing in North Oakland


Testing is quick and painless

No symptoms needed

No symptoms or referral required

How it works

Highly accurate qRT-PCR test helps diagnose current COVID infection. 

1. Schedule your test

Register and pay for your test online. Receive an appointment reminder via email/text.

2. Get tested

Fast, safe, and easy drive-through and walkup testing in North Oakland.

3. Get your result


The cost is $125. There's no insurance billing.

You can schedule and pre-pay using a credit card, or you can walk up and pay with a card or cash.




750 Aileen Street
Oakland, CA 94609


Weekdays 9a–5p
Weekends 10 am–2 pm 

Privacy Policy | 510-327-3483

Results and travel letter within 12 hours via secure web portal. 

Fast, highly accurate COVID-19 results

renegadeXP™ is our breakthrough qRT-PCR(also known as PCR or qPCR) diagnostic testing solution. Using samples collected via quick and painless nasal swab, it delivers results within 12 hours.    

Highly accurate (94.6%)

Safer for patients and staff alike

Non-invasive and painless

Request More Information

Your Privacy is Secure

#TestThePeople is a collaborative effort to make fast, accurate COVID testing accessible to all. We provide fast testing for individuals in the Bay Area. We also work with grassroots community health organizations to provide testing for at-risk communities.

SalivaDirect™ has not been FDA cleared or approved. It has been authorized by FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. 

About #TestThePeople